258 related articles for article (PubMed ID: 20797564)
41. Metabolic syndrome and renal disease.
Gluba A; Mikhailidis DP; Lip GY; Hannam S; Rysz J; Banach M
Int J Cardiol; 2013 Apr; 164(2):141-50. PubMed ID: 22305775
[TBL] [Abstract][Full Text] [Related]
42. Metabolic syndrome and chronic kidney disease.
Ching-Ha Kwan B; Beddhu S
Minerva Urol Nefrol; 2006 Mar; 58(1):1-12. PubMed ID: 16760879
[TBL] [Abstract][Full Text] [Related]
43. [Clinical importance and pathogenic mechanisms of insulin resistance in chronic renal insufficiency (part I): insulin resistance in patients with chronic renal insufficiency].
Rasić-Milutinović Z; Perunicić-Peković G
Med Pregl; 2000; 53(1-2):45-50. PubMed ID: 10953550
[TBL] [Abstract][Full Text] [Related]
44. [Epidemiological study on cardiovascular and renal diseases in Okinawa].
Takishita S
Nihon Rinsho; 2006 Aug; 64 Suppl 6():126-30. PubMed ID: 16981532
[No Abstract] [Full Text] [Related]
45. Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications.
Sarafidis PA; Ruilope LM
Am J Nephrol; 2006; 26(3):232-44. PubMed ID: 16733348
[TBL] [Abstract][Full Text] [Related]
46. The effect of obesity on chronic kidney disease.
Kopple JD; Feroze U
J Ren Nutr; 2011 Jan; 21(1):66-71. PubMed ID: 21195923
[TBL] [Abstract][Full Text] [Related]
47. Lipidomics is providing new insight into the metabolic syndrome and its sequelae.
Meikle PJ; Christopher MJ
Curr Opin Lipidol; 2011 Jun; 22(3):210-5. PubMed ID: 21378565
[TBL] [Abstract][Full Text] [Related]
48. Fighting protein-energy wasting in chronic kidney disease: a challenge of complexity.
Guarnieri G; Barazzoni R
J Ren Nutr; 2011 Jan; 21(1):2-6. PubMed ID: 21195908
[TBL] [Abstract][Full Text] [Related]
49. The Western-style diet: a major risk factor for impaired kidney function and chronic kidney disease.
Odermatt A
Am J Physiol Renal Physiol; 2011 Nov; 301(5):F919-31. PubMed ID: 21880837
[TBL] [Abstract][Full Text] [Related]
50. Is there an obesity-metabolic syndrome related glomerulopathy?
Ritz E; Koleganova N; Piecha G
Curr Opin Nephrol Hypertens; 2011 Jan; 20(1):44-9. PubMed ID: 21088574
[TBL] [Abstract][Full Text] [Related]
51. The influence of inflammation outweighing the metabolic syndrome on cardiovascular risk and mortality.
Lin GM; Chu KM; Han CL
Int J Cardiol; 2011 Feb; 146(3):431. PubMed ID: 21094539
[No Abstract] [Full Text] [Related]
52. Metabolic disorders following kidney transplantation.
Phillips S; Heuberger R
J Ren Nutr; 2012 Sep; 22(5):451-60.e1. PubMed ID: 22445053
[TBL] [Abstract][Full Text] [Related]
53. Metabolic diseases and cancer risk.
Faulds MH; Dahlman-Wright K
Curr Opin Oncol; 2012 Jan; 24(1):58-61. PubMed ID: 22123235
[TBL] [Abstract][Full Text] [Related]
54. [Impact of metabolic syndrome on chronic kidney disease].
Calò LA
Minerva Med; 2006 Dec; 97(6):451-8. PubMed ID: 17213781
[TBL] [Abstract][Full Text] [Related]
55. CYP450, COX-2 and Obesity Related Renal Damage.
Imig JD; Zhao X; Dey A; Shaw M
Toxicol Mech Methods; 2005; 15(2):125-36. PubMed ID: 20021073
[TBL] [Abstract][Full Text] [Related]
56. Hypertension in the metabolic syndrome.
Franklin SS
Metab Syndr Relat Disord; 2006; 4(4):287-98. PubMed ID: 18370747
[TBL] [Abstract][Full Text] [Related]
57. Relationship between smoking and metabolic syndrome.
Cena H; Fonte ML; Turconi G
Nutr Rev; 2011 Dec; 69(12):745-53. PubMed ID: 22133198
[TBL] [Abstract][Full Text] [Related]
58. Kidney in early atherosclerosis.
Chade AR; Lerman A; Lerman LO
Hypertension; 2005 Jun; 45(6):1042-9. PubMed ID: 15897370
[TBL] [Abstract][Full Text] [Related]
59. Evolving importance of kidney disease: from subspecialty to global health burden.
Eckardt KU; Coresh J; Devuyst O; Johnson RJ; Köttgen A; Levey AS; Levin A
Lancet; 2013 Jul; 382(9887):158-69. PubMed ID: 23727165
[TBL] [Abstract][Full Text] [Related]
60. Chronic kidney disease is a growing worldwide public health problem. Preface.
Blagg CR
Hemodial Int; 2011 Jul; 15(3):303-5. PubMed ID: 21722300
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
